Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Extracellular matrix wikipedia , lookup
Cytokinesis wikipedia , lookup
Tissue engineering wikipedia , lookup
Programmed cell death wikipedia , lookup
Cell growth wikipedia , lookup
Cell encapsulation wikipedia , lookup
Cell culture wikipedia , lookup
Organ-on-a-chip wikipedia , lookup
Cellular differentiation wikipedia , lookup
2016 DEPARTMENT OF MEDICINE RESEARCH DAY Title of Poster: Neuropeptide Y: a signature of functionally immature beta cells in pancreas development and diabetes Presenter: Sangeeta Dhawan Division: Endocrinology ☒ Faculty ☐ Fellow ☐ Resident ☐ Post-doc Research Fellow ☐ Graduate Student ☐ Medical Student ☐Other Principal Investigator/Mentor: Sangeeta Dhawan Georgia, Pope Rodnoi, Jalaal Abdul, Mohan Rajkumar Co-Investigators: Peter C. Butler, Alexandra E. Butler, Senta Thematic Poster Category: Development, Morphogenesis, Cell Growth and Differentiation, Apoptosis, Stem Cell Biology, Carcinogenesis and Cancer Biology Abstract Both type 1 and type 2 diabetes are caused by loss of functional beta cell mass. Cellular stress in diabetes induces a progressive loss of beta cell identity, and function, leading to eventual beta cell loss. Beta cell functional defects in evolving diabetes mimic the behavior of functionally immature beta cells in neonatal life, marked by an uncoupling of ambient glucose and insulin secretion. This emphasizes the importance of understanding mechanisms that regulate the functional maturation of beta cells. Beta cells are formed in embryonic life by differentiation of endocrine progenitors, rapidly expand by replication, and become functionally mature in late neonatal life. In this study, we identify Neuropeptide Y (NPY) as a marker of functionally immature beta cell identity in mouse and human beta cell development. NPY first emerges during embryonic pancreas development and labels subsets of nascently differentiated endocrine cells in mice and humans. NPY expression in beta cells is downregulated epigenetically, as these cells become functionally mature and quiescent. This downregulation is beta cell specific, as NPY persists in mature delta cells. The neonatal NPY positive beta cell subset is marked by higher replicative capacity. NPY is present in insulin secretory granules in neonatal beta cells, and knockdown of NPY in neonatal islets improves glucose stimulated insulin secretion. These data show that NPY expression in neonatal beta cells likely promotes replication and serves as a break to insulin secretion. We also show that NPY re-emerges in beta cells in diabetes, coinciding with impaired function, and supports the notion that cellular stress in diabetes leads to loss of mature beta cell identity and function. Together, these studies establish NPY as a valuable marker of immature beta cell identity that regulates replication and function, with potential applications to beta cell regeneration and diabetes therapy.